![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/constant-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-txa127-in-ischemic-stroke-recovery-302030169.html
https://www.biospace.com/article/releases/constant-therapeutics-txa127-for-covid-19-to-enter-nih-funded-clinical-trial-at-60-sites-around-the-u-s-/
https://www.prnewswire.com/news-releases/constant-therapeutics-announces-start-of-phase-2-trial-of-peptide-drug-txa127-for-covid-19-301101668.html
https://www.prnewswire.com/news-releases/constant-therapeutics-announces-start-of-phase-2-trial-of-peptide-drug-txa127-for-covid-19-301101668.html